Literature DB >> 35167085

Exploration of Protein Aggregations in Parkinson's Disease Through Computational Approaches and Big Data Analytics.

Saba Shahzadi1, Muhammad Yasir2, Bisma Aftab2, Sumbal Babar2, Mubashir Hassan3,4.   

Abstract

Protein aggregation has been implicated in numerous neurodegenerative disorders whose etiologies are poorly understood, and for which there are no effective treatments. Here we show that the computational approaches may help us to better understand the basics of Parkinson's disease (PD). The high-resolution structural, dynamical, and mechanistic insights delivered by computational studies of protein aggregation have a unique potential to enable the rational manipulation of oligomer formation. Additionally, big data and machine learning methods may provide valuable insights to better understand the nature of proteins involved in PD and their aggregative behavior for the betterment of PD treatment.
© 2022. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Big data; Parkinson’s disease; Protein aggregation

Mesh:

Substances:

Year:  2022        PMID: 35167085     DOI: 10.1007/978-1-0716-1546-1_19

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  52 in total

Review 1.  Profile of cognitive impairment in Parkinson's disease.

Authors:  G Stennis Watson; James B Leverenz
Journal:  Brain Pathol       Date:  2010-05       Impact factor: 6.508

Review 2.  Protein aggregation in the pathogenesis of familial and sporadic Parkinson's disease.

Authors:  Kevin St P McNaught; C Warren Olanow
Journal:  Neurobiol Aging       Date:  2005-10-03       Impact factor: 4.673

3.  Structural reorganization of alpha-synuclein at low pH observed by NMR and REMD simulations.

Authors:  Kuen-Phon Wu; Daniel S Weinstock; Chitra Narayanan; Ronald M Levy; Jean Baum
Journal:  J Mol Biol       Date:  2009-07-01       Impact factor: 5.469

4.  Determination of the free energy landscape of alpha-synuclein using spin label nuclear magnetic resonance measurements.

Authors:  Jane R Allison; Peter Varnai; Christopher M Dobson; Michele Vendruscolo
Journal:  J Am Chem Soc       Date:  2009-12-30       Impact factor: 15.419

Review 5.  Alpha-synuclein aggregation and neurodegenerative diseases.

Authors:  Qiu-Lan Ma; Piu Chan; Mitsunobu Yoshii; Kenji Uéda
Journal:  J Alzheimers Dis       Date:  2003-04       Impact factor: 4.472

6.  Parkinson's Disease and Its Management: Part 1: Disease Entity, Risk Factors, Pathophysiology, Clinical Presentation, and Diagnosis.

Authors:  George DeMaagd; Ashok Philip
Journal:  P T       Date:  2015-08

Review 7.  Protein misfolding and aggregation in Parkinson's disease.

Authors:  Jeanne M M Tan; Esther S P Wong; Kah-Leong Lim
Journal:  Antioxid Redox Signal       Date:  2009-09       Impact factor: 8.401

8.  Biology of Parkinson's disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorder.

Authors:  Garrett E Alexander
Journal:  Dialogues Clin Neurosci       Date:  2004-09       Impact factor: 5.986

9.  Cognitive impairment and dementia in Parkinson's disease: clinical features, diagnosis, and management.

Authors:  Joana Meireles; João Massano
Journal:  Front Neurol       Date:  2012-05-25       Impact factor: 4.003

10.  Alpha-synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity.

Authors:  Aaron D Gitler; Alessandra Chesi; Melissa L Geddie; Katherine E Strathearn; Shusei Hamamichi; Kathryn J Hill; Kim A Caldwell; Guy A Caldwell; Antony A Cooper; Jean-Christophe Rochet; Susan Lindquist
Journal:  Nat Genet       Date:  2009-02-01       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.